obfc1 antibody (oti2e4) Search Results


93
Novus Biologicals obfc1 stn1
(A) Western blot of <t>STN1</t> levels in HeLa iCas9 sgSTN1 cells, as indicated. Actinin serves as a loading control. DOX=Doxycycline. (B) Growth curve analysis of STN1 KO and control cells. D=day after DOX addition. n=3 independent, biological replicates. (C-D) Flow cytometry analysis of STN1 KO cells. (C) Representative histograms of STN1 KO and control (-DOX) cells. Left, histograms of DNA content versus cell count. Right, DNA content versus EdU intensity. (D) Percentage of G2/M cells over time in STN1 KO cells. n=3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test.
Obfc1 Stn1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/obfc1+antibody+%28oti2e4%29/bio_rxiv__2025__08__06__669015-183-1-3?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
obfc1 stn1 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Novus Biologicals anti stn1
(A) Western blot of <t>STN1</t> levels in HeLa iCas9 sgSTN1 cells, as indicated. Actinin serves as a loading control. DOX=Doxycycline. (B) Growth curve analysis of STN1 KO and control cells. D=day after DOX addition. n=3 independent, biological replicates. (C-D) Flow cytometry analysis of STN1 KO cells. (C) Representative histograms of STN1 KO and control (-DOX) cells. Left, histograms of DNA content versus cell count. Right, DNA content versus EdU intensity. (D) Percentage of G2/M cells over time in STN1 KO cells. n=3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test.
Anti Stn1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/obfc1+antibody+%28oti2e4%29/pmc08599947-55-20-22?v=Novus+Biologicals
Average 94 stars, based on 1 article reviews
anti stn1 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [Alexa Fluor® 532] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [DyLight 350] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence.
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [DyLight 755] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence.
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [PerCP] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence.
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) - Azide and BSA Free from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [HRP] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence.
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [PE/Cy5.5] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence.
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [Alexa Fluor® 700] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [Janelia Fluor® 646] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/
  Buy from Supplier

N/A
The OBFC1 Antibody (OTI2E4) [Alexa Fluor® 488] from Novus is a OBFC1 antibody to OBFC1. This antibody reacts with Human. The OBFC1 antibody has been validated for the following applications: Western Blot, Flow Cytometry, Immunocytochemistry/
  Buy from Supplier

Image Search Results


(A) Western blot of STN1 levels in HeLa iCas9 sgSTN1 cells, as indicated. Actinin serves as a loading control. DOX=Doxycycline. (B) Growth curve analysis of STN1 KO and control cells. D=day after DOX addition. n=3 independent, biological replicates. (C-D) Flow cytometry analysis of STN1 KO cells. (C) Representative histograms of STN1 KO and control (-DOX) cells. Left, histograms of DNA content versus cell count. Right, DNA content versus EdU intensity. (D) Percentage of G2/M cells over time in STN1 KO cells. n=3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test.

Journal: bioRxiv

Article Title: Conditional deletion of human STN1 leads to telomere dysfunction and telomerase-dependent genome instability and proliferation defects

doi: 10.1101/2025.08.06.669015

Figure Lengend Snippet: (A) Western blot of STN1 levels in HeLa iCas9 sgSTN1 cells, as indicated. Actinin serves as a loading control. DOX=Doxycycline. (B) Growth curve analysis of STN1 KO and control cells. D=day after DOX addition. n=3 independent, biological replicates. (C-D) Flow cytometry analysis of STN1 KO cells. (C) Representative histograms of STN1 KO and control (-DOX) cells. Left, histograms of DNA content versus cell count. Right, DNA content versus EdU intensity. (D) Percentage of G2/M cells over time in STN1 KO cells. n=3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test.

Article Snippet: Primary: OBFC1 (STN1) (Novus, NBP2-01006), Actinin (Santa Cruz, sc17829), pH3 S10 (Cell Signaling, 9706), RPA32 (Abcam, ab16850), and γH2AX (Bethyl, A300-081A; Abcam, ab81299).

Techniques: Western Blot, Control, Flow Cytometry, Cell Counting, Two Tailed Test

(A) Representative image of RPA-γH2AX foci. STN1 KO image is from day 12 after DOX addition. (B-C) Analysis of foci in STN1 KO and control (-DOX) cells. Percentage of nuclei displaying 3 or more RPA (B) or RPA-γH2AX foci (C). n=3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test. DOX=Doxycycline. D=day after DOX addition.

Journal: bioRxiv

Article Title: Conditional deletion of human STN1 leads to telomere dysfunction and telomerase-dependent genome instability and proliferation defects

doi: 10.1101/2025.08.06.669015

Figure Lengend Snippet: (A) Representative image of RPA-γH2AX foci. STN1 KO image is from day 12 after DOX addition. (B-C) Analysis of foci in STN1 KO and control (-DOX) cells. Percentage of nuclei displaying 3 or more RPA (B) or RPA-γH2AX foci (C). n=3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test. DOX=Doxycycline. D=day after DOX addition.

Article Snippet: Primary: OBFC1 (STN1) (Novus, NBP2-01006), Actinin (Santa Cruz, sc17829), pH3 S10 (Cell Signaling, 9706), RPA32 (Abcam, ab16850), and γH2AX (Bethyl, A300-081A; Abcam, ab81299).

Techniques: Control, Two Tailed Test

(A) Western blot of STN1 and Flag-STN1 levels, as indicated. KO+Flag-STN1 denotes STN1 KO cells expressing Flag-STN1. Actinin serves as a loading control. (B) Percentage of nuclei displaying 3 or more RPA foci on day 15 after DOX addition. n=3 independent, biological replicates. (C) Growth curve analysis, as indicated. n=3 independent, biological replicates. (D) Percentage of G2/M cells determined by flow cytometry on day 15 after DOX addition. n=4 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test. DOX=Doxycycline.

Journal: bioRxiv

Article Title: Conditional deletion of human STN1 leads to telomere dysfunction and telomerase-dependent genome instability and proliferation defects

doi: 10.1101/2025.08.06.669015

Figure Lengend Snippet: (A) Western blot of STN1 and Flag-STN1 levels, as indicated. KO+Flag-STN1 denotes STN1 KO cells expressing Flag-STN1. Actinin serves as a loading control. (B) Percentage of nuclei displaying 3 or more RPA foci on day 15 after DOX addition. n=3 independent, biological replicates. (C) Growth curve analysis, as indicated. n=3 independent, biological replicates. (D) Percentage of G2/M cells determined by flow cytometry on day 15 after DOX addition. n=4 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test. DOX=Doxycycline.

Article Snippet: Primary: OBFC1 (STN1) (Novus, NBP2-01006), Actinin (Santa Cruz, sc17829), pH3 S10 (Cell Signaling, 9706), RPA32 (Abcam, ab16850), and γH2AX (Bethyl, A300-081A; Abcam, ab81299).

Techniques: Western Blot, Expressing, Control, Flow Cytometry, Two Tailed Test

(A) Representative image of an anaphase bridge (indicated by the arrow) in STN1 KO cells. (B-C) Percentage of anaphase bridges in STN1 KO and control (-DOX) cells between days 5-15 (B) or with expression of exogenous Flag-STN1 on day 15 (C). n=≥3 independent, biological replicates. (D) Representative image of micronuclei (indicated by the arrows) in the STN1 KO cells. (E-F) Percentage of cells with micronuclei in STN1 KO and control cells between days 5-15 (E) or with expression of exogenous Flag-STN1 on day 15 (F). n=≥3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test. DOX=Doxycycline. D=day after DOX addition.

Journal: bioRxiv

Article Title: Conditional deletion of human STN1 leads to telomere dysfunction and telomerase-dependent genome instability and proliferation defects

doi: 10.1101/2025.08.06.669015

Figure Lengend Snippet: (A) Representative image of an anaphase bridge (indicated by the arrow) in STN1 KO cells. (B-C) Percentage of anaphase bridges in STN1 KO and control (-DOX) cells between days 5-15 (B) or with expression of exogenous Flag-STN1 on day 15 (C). n=≥3 independent, biological replicates. (D) Representative image of micronuclei (indicated by the arrows) in the STN1 KO cells. (E-F) Percentage of cells with micronuclei in STN1 KO and control cells between days 5-15 (E) or with expression of exogenous Flag-STN1 on day 15 (F). n=≥3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test. DOX=Doxycycline. D=day after DOX addition.

Article Snippet: Primary: OBFC1 (STN1) (Novus, NBP2-01006), Actinin (Santa Cruz, sc17829), pH3 S10 (Cell Signaling, 9706), RPA32 (Abcam, ab16850), and γH2AX (Bethyl, A300-081A; Abcam, ab81299).

Techniques: Control, Expressing, Two Tailed Test

Cells were treated with a telomerase inhibitor (BIBR) or DMSO starting with the addition of DOX on day 0 to the sgSTN1 cells. The control cells were also treated with BIBR or DMSO across the same timeframe. (A-B) Percentage of nuclei with 3 or more RPA (A) or RPA-γH2AX (B) foci in STN1 KO or control cells with or without BIBR treatment. n=3 independent, biological replicates. (C-D) Percentage of micronuclei (C) or anaphase bridges (D) on day 15 after DOX addition with and without BIBR treatment. n=4 independent, biological replicates. (E) Growth curve analysis, as indicated. n=3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test. DOX=Doxycycline. D=day after DOX addition.

Journal: bioRxiv

Article Title: Conditional deletion of human STN1 leads to telomere dysfunction and telomerase-dependent genome instability and proliferation defects

doi: 10.1101/2025.08.06.669015

Figure Lengend Snippet: Cells were treated with a telomerase inhibitor (BIBR) or DMSO starting with the addition of DOX on day 0 to the sgSTN1 cells. The control cells were also treated with BIBR or DMSO across the same timeframe. (A-B) Percentage of nuclei with 3 or more RPA (A) or RPA-γH2AX (B) foci in STN1 KO or control cells with or without BIBR treatment. n=3 independent, biological replicates. (C-D) Percentage of micronuclei (C) or anaphase bridges (D) on day 15 after DOX addition with and without BIBR treatment. n=4 independent, biological replicates. (E) Growth curve analysis, as indicated. n=3 independent, biological replicates. Average values in the graphs indicate the mean and error bars denote ±s.e.m. P -values were calculated by a two-tailed, unpaired t -test. DOX=Doxycycline. D=day after DOX addition.

Article Snippet: Primary: OBFC1 (STN1) (Novus, NBP2-01006), Actinin (Santa Cruz, sc17829), pH3 S10 (Cell Signaling, 9706), RPA32 (Abcam, ab16850), and γH2AX (Bethyl, A300-081A; Abcam, ab81299).

Techniques: Control, Two Tailed Test